What Happened?
South San Francisco, CA-based FLX Bio Appointed Brian Wong as Chief Executive Officer
About the Company
FLX Bio, Inc. is a biotechnology company focused on the discovery and development of novel therapies that will improve and prolong the lives of people with cancer. The company is targeting key cancer pathways with its clinical-stage program, FLX925, and building a pipeline of immuno-oncology oral medicines designed to activate a patient`s own immune system to eradicate cancer.
About the Person
Brian Wong is Chief Executive Officer at FLX Bio. Previously, Brian held various senior HR leadership roles in the industry.
Info Source
News
Short Profile